FENC- Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. (FENC) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. FENC is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $30.49M | - | |
| CFO | 289.3K | $3.21M | - | |
| Dir | 139.8K | $1.55M | -9,747 | |
| CEO | 62.8K | $698.0K | - | |
| Dir | 58.9K | $653.9K | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Raykov Rosty54 | Director | Sell | 10,000 | $8.92 | $89,200.00 | -16.4% | -17.5% | - | |
| Aug 5, 2025 | Raykov Rosty54 | Director | Sell | 10,000 | $8.09 | $80,900.00 | -15.2% | -0.5% | - | |
| Jul 7, 2025 | Rallis Chris A62 | Director | Sale+OE | 1,119 | $8.71 | $9,746.49 | -2.0% | +15.0% | - | |
| Jul 3, 2025 | Raykov Rosty54 | Director | Sell | 10,000 | $8.61 | $86,100.00 | -14.2% | +9.0% | - | |
| Jun 5, 2025 | Raykov Rosty54 | Director | Sell | 10,000 | $7.78 | $77,800.00 | -13.3% | +12.2% | +10.1% | |
| May 19, 2025 | Hackman Jeffrey S. | Chief Executive Officer | Buy | 15,000 | $6.97 | $104,601.60 | +1,449% | +7.2% | +27.6% | |
| May 16, 2025 | Raykov Rosty54 | Director | Sell | 16,667 | $6.78 | $113,002.26 | -19.2% | +24.7% | +42.5% | |
| May 5, 2025 | Raykov Rosty54 | Director | Sell | 10,000 | $6.31 | $63,100.00 | -15.7% | +32.5% | +7.0% | |
| Apr 11, 2025 | Rallis Chris A62 | Director | Sale+OE | 1,409 | $4.95 | $6,974.55 | -2.6% | +80.4% | +16.0% | |
| Apr 4, 2025 | Raykov Rosty54 | Director | Sell | 10,000 | $5.25 | $52,500.00 | -14.1% | +67.6% | +22.3% |